By requiring systems of drug supply safety and quality both abroad and at home, by funding an increase in inspectors, by improving the import system, and increasing penalties, the bill will make fundamental improvements in American drug safety. Basically, the bill will change the current system where the FDA plays chase and catch-up, to a system where suppliers will have to be pro-active on specific safety and quality issues and the FDA will have more resources to verify compliance with reasonable safety requirements.